Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) hit a new 52-week low on Friday . The stock traded as low as €15.40 and last traded at €16.02, with a volume of 1057900 shares traded. The stock had previously closed at €16.02.
Analyst Ratings Changes
Several equities analysts have recently commented on STVN shares. Weiss Ratings restated a “hold (c)” rating on shares of Stevanato Group in a research report on Monday, December 29th. Morgan Stanley began coverage on shares of Stevanato Group in a research report on Monday, December 1st. They issued an “equal weight” rating and a $24.00 target price for the company. Finally, Wall Street Zen raised Stevanato Group from a “hold” rating to a “buy” rating in a report on Friday, January 23rd. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy”.
Check Out Our Latest Report on Stevanato Group
Stevanato Group Price Performance
Institutional Investors Weigh In On Stevanato Group
Several hedge funds and other institutional investors have recently added to or reduced their stakes in STVN. Farther Finance Advisors LLC acquired a new stake in Stevanato Group in the third quarter worth approximately $44,000. First Horizon Corp bought a new stake in shares of Stevanato Group in the 3rd quarter worth $50,000. State of Wyoming raised its stake in shares of Stevanato Group by 39,216.7% in the 2nd quarter. State of Wyoming now owns 2,359 shares of the company’s stock worth $58,000 after buying an additional 2,353 shares in the last quarter. Quantbot Technologies LP bought a new position in Stevanato Group during the third quarter valued at about $68,000. Finally, Van Berkom & Associates Inc. grew its holdings in Stevanato Group by 50.6% during the third quarter. Van Berkom & Associates Inc. now owns 3,615 shares of the company’s stock worth $93,000 after acquiring an additional 1,215 shares during the period.
Stevanato Group Company Profile
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
Read More
- Five stocks we like better than Stevanato Group
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- New Banking Law #1582 Could Unlock $21 Trillion for Americans
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Buy this Gold Stock Before May 2026
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
